BioCorRx (BICX) Revenue Growth (1y) (2012 - 2026)
BioCorRx (BICX) Revenue Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 8.73% |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 6.77% |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 9.58% |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 5.17% |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 17.33% |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 8.27% |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 9.07% |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 8.80% |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 10.03% |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.04% |
| Jun 30, 2025 | 4,306.38% |
| Mar 31, 2025 | 3,626.49% |
| Jun 30, 2024 | -79.40% |
| Mar 31, 2024 | -91.05% |
| Dec 31, 2023 | -77.15% |
| Sep 30, 2023 | -89.26% |
| Jun 30, 2023 | 22.70% |
| Mar 31, 2023 | 97.10% |
| Dec 31, 2022 | 508.83% |
| Sep 30, 2022 | 971.12% |
| Jun 30, 2022 | 1.81% |
| Mar 31, 2022 | 102.67% |
| Dec 31, 2021 | -38.74% |
| Sep 30, 2021 | -70.42% |
| Jun 30, 2021 | -53.35% |
| Mar 31, 2021 | -72.56% |
| Dec 31, 2020 | -64.42% |
| Sep 30, 2020 | -35.98% |
| Jun 30, 2020 | -48.93% |